Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials group

References

Page 1

	Year	Citations
Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol Israel Ringel, Susan Band Horwitz JNCI Journal of the National Cancer Institute Bioorganic ChemistryOrganic ChemistryCytoskeletonChemical BiologyCancer Biology	1991	672
Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Marie-Christine Bissery, Daniel Guénard, Françoise Guéritte-Voegelein, PubMed Lewis LungPharmacotherapyPharmaceutical ChemistryTumor BiologyNew Microtubule	1991	481
Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion. Jean Marc Extra, Frédérique Rousseau, René Bruno, PubMed Chemoprevention StrategyPharmacokinetic StudyPharmacotherapyMetronomic ChemotherapyDermatology	1993	253
Coping with toxicities of docetaxel (TaxotereTM) D. Schrijvers, J. Wanders, Luc Dirix, Annals of Oncology PharmacologyPoisoningToxicologyPharmacotherapyMedicine	1993	143
Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion. D. Bissett, A Setanoians, J Cassidy, PubMed Pharmaceutical SciencePharmacokinetic StudyPathologyPharmacotherapyMetronomic Chemotherapy	1993	139
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion. Howard A. Burris, Rebecca Irvin, John G. Kuhn, Journal of Clinical Oncology	1993	135
Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents Marianne Vogel, Susan G. Hilsenbeck, H. Depenbrock, European Journal of Cancer Tumor BiologyOncologyMalignant DiseasePreclinical ActivityMedicine	1993	44
Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer Epie Boven, E. Venema-Gaberscek, CAM Erkelens, Annals of Oncology Medicinal ChemistryAntitumor ActivityExperimental Ovarian CancerMedicinePharmacology	1993	25
A phase I study of Taxotere (RP 56976 NSC 628503) administered as a one hour intravenous infusion on a weekly basis Eva Tomiak, Martine Piccart, Joseph Kerger, Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)	1991	16

Page 1